LRP2 and colorectal adenocarcinoma: The results exhibited that in colorectal adenocarcinoma, endometrial carcinoma and esophagogastric adenocarcinoma, patients with LRP2 mutations had higher MSIsensor score than those without LRP2 mutations (Fig. S1B).